{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:22:56Z","timestamp":1773696176721,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the General Project of Nanjing Medical Science and Technology Development","award":["YKK19057"],"award-info":[{"award-number":["YKK19057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10157-022-02209-w","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T04:40:28Z","timestamp":1648183228000},"page":"630-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of IGF-1R in epithelial\u2013mesenchymal transdifferentiation of human peritoneal mesothelial cells"],"prefix":"10.1007","volume":"26","author":[{"given":"Yangyang","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"2209_CR1","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","volume":"27","author":"R Mehrotra","year":"2016","unstructured":"Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27:3238\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"2209_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13:470\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"2209_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/BCR.0b013e318240541e","volume":"33","author":"CE Weber","year":"2012","unstructured":"Weber CE, Li NY, Wai PY, Kuo PC. Epithelial-mesenchymal transition, tgf-beta, and osteopontin in wound healing and tissue remodeling after injury. J Burn Care Res. 2012;33:311\u20138.","journal-title":"J Burn Care Res"},{"key":"2209_CR4","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2006111292","volume":"18","author":"LS Aroeira","year":"2007","unstructured":"Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, Del PG, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007;18:2004\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"2209_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871\u201390.","journal-title":"Cell"},{"key":"2209_CR6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG. Biomarkers for epithelial\u2013mesenchymal transitions. J Clin Invest. 2009;119:1429\u201337.","journal-title":"J Clin Invest"},{"key":"2209_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1681\/ASN.2008040424","volume":"20","author":"MA Yu","year":"2009","unstructured":"Yu MA, Shin KS, Kim JH, Kim YI, Chung SS, et al. Hgf and bmp-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol. 2009;20:567\u201381.","journal-title":"J Am Soc Nephrol"},{"key":"2209_CR8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0008-6363(95)00163-8","volume":"30","author":"P Delafontaine","year":"1995","unstructured":"Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc Res. 1995;30:825\u201334.","journal-title":"Cardiovasc Res"},{"key":"2209_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1210\/edrv-16-2-143","volume":"16","author":"D LeRoith","year":"1995","unstructured":"LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 1995;16:143\u201363.","journal-title":"Endocr Rev"},{"key":"2209_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/(SICI)1097-0215(19971210)73:6<885::AID-IJC21>3.0.CO;2-2","volume":"73","author":"BC van der Wal","year":"1997","unstructured":"van der Wal BC, Hofland LJ, Marquet RL, van Koetsveld PM, et al. Paracrine interactions between mesothelial and colon-carcinoma cells in a rat model. Int J Cancer. 1997;73:885\u201390.","journal-title":"Int J Cancer"},{"key":"2209_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","volume":"24","author":"P Delafontaine","year":"2004","unstructured":"Delafontaine P, Song Y-H, Expression YL. Regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol. 2004;24:435\u201344.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"25","key":"2209_CR12","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1038\/s41388-018-0222-3","volume":"37","author":"PC Chu","year":"2018","unstructured":"Chu PC, Lin PC, Wu HY, et al. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway. Oncogene. 2018;37(25):3440\u201355.","journal-title":"Oncogene"},{"key":"2209_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00432-015-2039-6","volume":"142","author":"K Numata","year":"2016","unstructured":"Numata K, Oshima T, Sakamaki K, et al. Clinical significance of IGF1R gene expression in patients with stage ii\/iii gastric cancer who receive curative surgery and adjuvant chemotherapy with s-1. J Cancer Res Clin Oncol. 2016;142:415\u201322.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2209_CR14","first-page":"7000","volume":"15","author":"C Su","year":"2018","unstructured":"Su C, Wang W, Wang C. IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1\/STAT3 signaling pathway. Oncol Lett. 2018;15:7000\u20136.","journal-title":"Oncol Lett"},{"key":"2209_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exer.2011.12.006","volume":"94","author":"DM Robertson","year":"2012","unstructured":"Robertson DM, Zhu M, Wu YC. Cellular distribution of the IGF-1R in corneal epithelial cells. Exp Eye Res. 2012;94:179\u201386.","journal-title":"Exp Eye Res"},{"issue":"6","key":"2209_CR16","first-page":"106","volume":"3","author":"OT Cox","year":"2015","unstructured":"Cox OT, O\u2019Shea S, Tresse E, Bustamante-Garrido M, et al. IGF-1 receptor and adhesion signaling: an important axis in determining cancer cell phenotype and therapy resistance. Front Endocrinol (Lausanne). 2015;3(6):106.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"2209_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2131","volume":"7","author":"H Peinado","year":"2007","unstructured":"Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7(6):415\u201328.","journal-title":"Nat Rev Cancer"},{"key":"2209_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1101\/gad.294104","volume":"18","author":"S Vega","year":"2004","unstructured":"Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, et al. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 2004;18:1131\u201343.","journal-title":"Genes Dev"},{"issue":"3","key":"2209_CR19","first-page":"1473","volume":"11","author":"J Liu","year":"2019","unstructured":"Liu J, Jiang C-M, Feng Y, Zhu W, et al. Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum. Am J Transl Res. 2019;11(3):1473\u201385.","journal-title":"Am J Transl Res"},{"key":"2209_CR20","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1093\/ndt\/gfn369","volume":"23","author":"K-Y Hung","year":"2008","unstructured":"Hung K-Y, Huang J-W, Chiang C-K, Tsai T-J. Preservation of peritoneal morphology and function by pentoxifyllinein a rat model of peritoneal dialysis: molecular studies. Nephrol Dial Transpl. 2008;23:3831\u201340.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"2209_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/089686080202200103","volume":"22","author":"Y Ishibashi","year":"2002","unstructured":"Ishibashi Y, Sugimoto T, Ichikawa Y, et al. Glucose dialysate induces mitochondrial DNA damage in peritoneal mesothelial cells. Perit Dial Int. 2002;22(1):11\u201321.","journal-title":"Perit Dial Int"},{"issue":"2","key":"2209_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/039139880502800203","volume":"28","author":"C Pollock","year":"2005","unstructured":"Pollock C. Pathogenesis of peritoneal sclerosis. Int J Artif Org. 2005;28(2):90\u20136.","journal-title":"Int J Artif Org"},{"key":"2209_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3747\/pdi.2014.00188","volume":"35","author":"Y Liu","year":"2015","unstructured":"Liu Y, Dong Z, Liu H, Zhu J, Liu F, Chen G. Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander? Peritoneal Dial Int J Int Soc Peritoneal Dial. 2015;35:14\u201325.","journal-title":"Peritoneal Dial Int J Int Soc Peritoneal Dial."},{"key":"2209_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/labinvest.2015.91","volume":"95","author":"HS Shin","year":"2015","unstructured":"Shin HS, Ryu ES, Oh ES, Kang DH. Endoplasmic reticulum stress as a novel target to ameliorate epithelial-to-mesenchymal transition and apoptosis of human peritoneal mesothelial cells. Lab Investig. 2015;95:1157\u201373.","journal-title":"Lab Investig."},{"key":"2209_CR25","first-page":"53","volume":"17","author":"Z Zheng","year":"2001","unstructured":"Zheng Z, Ye R, Yu X, et al. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model. Adv Perit Dial. 2001;17:53\u20137.","journal-title":"Adv Perit Dial"},{"issue":"1","key":"2209_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbcan.2018.10.003","volume":"1871","author":"E Tulchinsky","year":"2019","unstructured":"Tulchinsky E, Demidov O, Kriajevska M, Barlev NA, Imyanitov E. EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer. Biochim Biophys Acta Rev Cancer. 2019;1871(1):29\u201339.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"2209_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0305-0491(88)90137-X","volume":"91","author":"RC Baxter","year":"1988","unstructured":"Baxter RC. The insulin-like growth factors and their binding proteins. Comp Biochem Physiol B. 1988;91(2):229\u201335.","journal-title":"Comp Biochem Physiol B"},{"key":"2209_CR28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1210\/jc.2010-1255","volume":"96","author":"R Malaguarnera","year":"2011","unstructured":"Malaguarnera R, Frasca F, Garozzo A, Giani F, Pandini G, Vella V, et al. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrinol Metab. 2011;96:766\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"2209_CR29","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1038\/ncomms4472","volume":"5","author":"WJ Chen","year":"2014","unstructured":"Chen WJ, Ho CC, Chang YL, Chen HY, Lin CA, Ling TY, et al. Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nat Commun. 2014;5:3472.","journal-title":"Nat Commun"},{"key":"2209_CR30","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1038\/onc.2013.373","volume":"33","author":"IG Kim","year":"2014","unstructured":"Kim IG, Kim SY, Choi SI, Lee JH, Kim KC, Cho EW. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+lung cancer stem cells through IGF-1R signaling. Oncogene. 2014;33:3908\u201317.","journal-title":"Oncogene"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02209-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-022-02209-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02209-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T14:06:00Z","timestamp":1655388360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-022-02209-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2209"],"URL":"https:\/\/doi.org\/10.1007\/s10157-022-02209-w","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}